Roche (OTCQX:RHHBY) has received FDA clearance with a CLIA waiver for its cobas liat sexually transmitted infection, or STI, multiplex assay panels. The tests will be available exclusively in the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback